Literature DB >> 30499379

Targeting LINC00673 expression triggers cellular senescence in lung cancer.

Anna Roth1, Karine Boulay1, Matthias Groß1, Maria Polycarpou-Schwarz1, Frédérick A Mallette2, Marine Regnier2, Or Bida3, Doron Ginsberg3, Arne Warth4,5, Philipp A Schnabel4, Thomas Muley5,6, Michael Meister5,6, Heike Zabeck6, Hans Hoffmann6, Sven Diederichs1,7,8.   

Abstract

Aberrant expression of noncoding RNAs plays a critical role during tumorigenesis. To uncover novel functions of long non-coding RNA (lncRNA) in lung adenocarcinoma, we used a microarray-based screen identifying LINC00673 with elevated expression in matched tumor versus normal tissue. We report that loss of LINC00673 is sufficient to trigger cellular senescence, a tumor suppressive mechanism associated with permanent cell cycle arrest, both in lung cancer and normal cells in a p53-dependent manner. LINC00673-depleted cells fail to efficiently transit from G1- to S-phase. Using a quantitative proteomics approach, we confirm the modulation of senescence-associated genes as a result of LINC00673 knockdown. In addition, we uncover that depletion of p53 in normal and tumor cells is sufficient to overcome LINC00673-mediated cell cycle arrest and cellular senescence. Furthermore, we report that overexpression of LINC00673 reduces p53 translation and contributes to the bypass of Ras-induced senescence. In summary, our findings highlight LINC00673 as a crucial regulator of proliferation and cellular senescence in lung cancer.

Entities:  

Keywords:  long noncoding RNA; lung cancer; p53; senescence

Mesh:

Substances:

Year:  2018        PMID: 30499379      PMCID: PMC6333431          DOI: 10.1080/15476286.2018.1553481

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  78 in total

Review 1.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

2.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

Review 3.  Molecular pathways: harnessing E2F1 regulation for prosenescence therapy in p53-defective cancer cells.

Authors:  Anni Laine; Jukka Westermarck
Journal:  Clin Cancer Res       Date:  2014-05-01       Impact factor: 12.531

4.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

5.  BRAFE600-associated senescence-like cell cycle arrest of human naevi.

Authors:  Chrysiis Michaloglou; Liesbeth C W Vredeveld; Maria S Soengas; Christophe Denoyelle; Thomas Kuilman; Chantal M A M van der Horst; Donné M Majoor; Jerry W Shay; Wolter J Mooi; Daniel S Peeper
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

6.  Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence.

Authors:  Frédérick A Mallette; Stéphane Goumard; Marie-France Gaumont-Leclerc; Olga Moiseeva; Gerardo Ferbeyre
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

7.  The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.

Authors:  D Guan; D Factor; Yu Liu; Z Wang; H-Y Kao
Journal:  Oncogene       Date:  2012-09-03       Impact factor: 9.867

8.  Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals.

Authors:  Hidenori Tani; Rena Mizutani; Kazi Abdus Salam; Keiko Tano; Kenichi Ijiri; Ai Wakamatsu; Takao Isogai; Yutaka Suzuki; Nobuyoshi Akimitsu
Journal:  Genome Res       Date:  2012-02-27       Impact factor: 9.043

Review 9.  TP53 mutations in nonsmall cell lung cancer.

Authors:  Akira Mogi; Hiroyuki Kuwano
Journal:  J Biomed Biotechnol       Date:  2011-01-18

10.  A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel.

Authors:  Or Bida; Moriah Gidoni; Diana Ideses; Sol Efroni; Doron Ginsberg
Journal:  Oncotarget       Date:  2015-09-29
View more
  12 in total

1.  A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers.

Authors:  Rongjie Cheng; Fanying Li; Maolei Zhang; Xin Xia; Jianzhuang Wu; Xinya Gao; Huangkai Zhou; Zhi Zhang; Nunu Huang; Xuesong Yang; Yaliang Zhang; Shunli Shen; Tiebang Kang; Zexian Liu; Feizhe Xiao; Hongwei Yao; Jianbo Xu; Chao Yan; Nu Zhang
Journal:  Cell Res       Date:  2022-10-14       Impact factor: 46.297

Review 2.  Emerging Role of Non-Coding RNAs in Senescence.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Aria Baniahmad; Wojciech Branicki; Mohammad Taheri; Ahmad Eghbali
Journal:  Front Cell Dev Biol       Date:  2022-07-05

Review 3.  AFAP1-AS1: a rising star among oncogenic long non-coding RNAs.

Authors:  Fang Xiong; Kunjie Zhu; Su Deng; Hongbin Huang; Liting Yang; Zhaojian Gong; Lei Shi; Yi He; Yanyan Tang; Qianjin Liao; Jianjun Yu; Xiaoling Li; Yong Li; Guiyuan Li; Zhaoyang Zeng; Wei Xiong; Shanshan Zhang; Can Guo
Journal:  Sci China Life Sci       Date:  2021-05-13       Impact factor: 6.038

4.  A novel E2F1-regulated lncRNA, LAPAS1, is required for S phase progression and cell proliferation.

Authors:  Esther Baruch; Tali Nizri-Megnaji; Oron Berkowitz; Doron Ginsberg
Journal:  Oncotarget       Date:  2021-05-25

5.  The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer.

Authors:  Minakshi Gandhi; Matthias Groß; Jessica M Holler; Si'Ana A Coggins; Nitin Patil; Joerg H Leupold; Mathias Munschauer; Monica Schenone; Christina R Hartigan; Heike Allgayer; Baek Kim; Sven Diederichs
Journal:  Nat Commun       Date:  2020-06-25       Impact factor: 14.919

6.  The Circular RNA Landscape of Non-Small Cell Lung Cancer Cells.

Authors:  Nele Van Der Steen; Yanhong Lyu; Anne K Hitzler; Andrea C Becker; Jeanette Seiler; Sven Diederichs
Journal:  Cancers (Basel)       Date:  2020-04-28       Impact factor: 6.639

7.  Additional data support the role of LINC00673 rs11655237 C>T in the development of neuroblastoma.

Authors:  Yong Li; Zhen-Jian Zhuo; Haiyan Zhou; Jiabin Liu; Zan Liu; Jiao Zhang; Jiwen Cheng; Suhong Li; Haixia Zhou; Rong Zhou; Jing He; Yaowang Zhao
Journal:  Aging (Albany NY)       Date:  2019-04-20       Impact factor: 5.682

8.  The lncRNA SLNCR Recruits the Androgen Receptor to EGR1-Bound Genes in Melanoma and Inhibits Expression of Tumor Suppressor p21.

Authors:  Karyn Schmidt; Johanna S Carroll; Elaine Yee; Dolly D Thomas; Leon Wert-Lamas; Steven C Neier; Gloria Sheynkman; Justin Ritz; Carl D Novina
Journal:  Cell Rep       Date:  2019-05-21       Impact factor: 9.423

9.  Long noncoding RNA LINC00673-v4 promotes aggressiveness of lung adenocarcinoma via activating WNT/β-catenin signaling.

Authors:  Hongyu Guan; Ting Zhu; Shanshan Wu; Shihua Liu; Bangdong Liu; Jueheng Wu; Junchao Cai; Xun Zhu; Xin Zhang; Musheng Zeng; Jun Li; Erwei Song; Mengfeng Li
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

10.  Overexpression of LINC00673 Promotes the Proliferation of Cervical Cancer Cells.

Authors:  Sheng-Kai Huang; Ruo-Xuan Ni; Wen-Jie Wang; Di Wang; Mei Zhao; Cheng-Zhi Lei; Xiao-Jie Sun; Chang-Zhi Huang; Ping Bai; Yi-Qun Che; Jian-Ping Xu
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.